Canada markets closed

Seres Therapeutics, Inc. (MCRB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.8485+0.0113 (+1.35%)
At close: 04:00PM EDT
0.8570 +0.01 (+1.00%)
After hours: 07:46PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 144.41M
Enterprise Value 285.81M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)315.38
Price/Book (mrq)63.84
Enterprise Value/Revenue 764.19
Enterprise Value/EBITDA -2.07

Trading Information

Stock Price History

Beta (5Y Monthly) 2.02
52-Week Change 3-53.98%
S&P500 52-Week Change 332.65%
52 Week High 32.0500
52 Week Low 30.5400
50-Day Moving Average 30.9813
200-Day Moving Average 30.9846

Share Statistics

Avg Vol (3 month) 34.39M
Avg Vol (10 day) 36.83M
Shares Outstanding 5170.2M
Implied Shares Outstanding 6170.2M
Float 8105.91M
% Held by Insiders 114.75%
% Held by Institutions 145.40%
Shares Short (Sept 13, 2024) 417.22M
Short Ratio (Sept 13, 2024) 45.06
Short % of Float (Sept 13, 2024) 415.76%
Short % of Shares Outstanding (Sept 13, 2024) 411.30%
Shares Short (prior month Aug 15, 2024) 416.75M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-42,211.23%

Management Effectiveness

Return on Assets (ttm)-27.10%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)374k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -151.58M
Net Income Avi to Common (ttm)-162.1M
Diluted EPS (ttm)-1.1900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)71.23M
Total Cash Per Share (mrq)0.47
Total Debt (mrq)212.62M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.38
Book Value Per Share (mrq)-0.57

Cash Flow Statement

Operating Cash Flow (ttm)-181.8M
Levered Free Cash Flow (ttm)-98.53M